Skip to content

The expression of TGF-beta 2, bFGF and ICAM-1on complicated cataract in the silicon oil tamponaded eyes

The expression of TGF-beta 2, bFGF and ICAM-1on complicated cataract in the silicon oil tamponaded eyes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPC-15005811
Enrollment
Unknown
Registered
2014-12-21
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

intervention group:silcon oil
control group:Nil

Sponsors

Xian No. 4 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 66 Years

Inclusion criteria

Inclusion criteria: 1. The required operation for treatment of complicated cataract after silicone oil infusion and in patients with age-related cataract patients with a total of 60 cases, including 30 cases of complicated cataract after silicone oil infusion patients, 30 patients with age-related cataract; 2. All the complicated cataract after silicone oil infusion in patients with previous vitrectomy operation by the same operation to complete; 3. Cataract operation have the same operation completed by ultrasonic emulsification operation; 4. Inclusion criteria refer to LOCS III classification standard.

Exclusion criteria

Exclusion criteria: 1. Can not tolerate surgery; 2. Ocular complications caused by Diabetes and severe systemic diseases; 3. With a history of ocular trauma history or other ocular disease complicated with cataract; 4. Mechanical injury of lens in the Vitrectomy; 5. Not adhering to treatment and failing to follow by the research plan according to plan.

Design outcomes

Primary

MeasureTime frame
TGF-beta 2;bFGF;ICAM-1;

Countries

China

Contacts

Public ContactLiu Bei
liubei1031@163.com+86 13572259492

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026